Features | Partner Sites | Information | LinkXpress
Sign In
RANDOX LABORATORIES
AB Sciex
FOCUS DIAGNOSTICS, INC.

Fiber-Optic Microscope Helps Detect Cancer

By Labmedica International staff writers
Posted on 01 May 2014
Images: High-resolution fiber-optic endoscopic microscope reveals some of the same tissue features as conventional histology on a biopsied sample. Healthy oral mucosa: (a) endoscopic microscope; (b) conventional histology. Oral cancer: (c) endoscopic microscope; (d) conventional histology (Photo courtesy of the US National Institute of Health).
Images: High-resolution fiber-optic endoscopic microscope reveals some of the same tissue features as conventional histology on a biopsied sample. Healthy oral mucosa: (a) endoscopic microscope; (b) conventional histology. Oral cancer: (c) endoscopic microscope; (d) conventional histology (Photo courtesy of the US National Institute of Health).
An inexpensive, portable and reusable endoscopic microscope has been developed that will help clinicians detect and diagnose early-stage disease, primarily cancer.

An endoscopic microscope is a tool or technique that obtains histological images from inside the human body in real-time and some clinicians consider it as an optical biopsy.

An engineering scientist at the University of Arkansas (Fayetteville, AR, USA) has developed an inexpensive, endoscopic microscope capable of producing high-resolution, subcellular images of tissue in real time. The fiber-optic device, which is portable, reusable and easily packaged with conventional endoscopes, will help clinicians detect and diagnose early-stage disease, primarily cancer.

The system, developed also serves as an intraoperative monitoring device by providing a preview biopsy that is, helping clinicians target ideal locations on lesions prior to and during surgical biopsies and by capturing high-resolution images of tumor margins in real time. The latter will help surgeons know whether they have totally removed a tumor. The microscope is built from a single fiber optic bundle that includes thousands of flexible, small-caliber fibers. This bundle is roughly one millimeter in diameter and could be inserted into the biopsy channel of a standard endoscope.

The system requires a topical contrast agent to facilitate fluorescent imaging. It can produce images at sub-cellular resolution, which allows clinicians to see the early stages of cell deformations that could lead to precancerous conditions. The probe can be sterilized and reused. The entire system, which fits into a conventional-sized briefcase, costs approximately USD 2,500.

A prototype of the system has been tested at the M.D. Anderson Cancer Center (Houston, TX, USA). Studies there focused on various conditions leading to esophageal cancer. The work provided high-resolution images of cell structure and morphology, specifically nuclear-to-cytoplasmic ratio, a critical indicator of cell behavior leading up to a precancerous condition. Results obtained from the endoscopic microscope were confirmed by standard histopathological examination of biopsied tissue.

Timothy Muldoon, MD, PhD, an assistant professor of biomedical engineering who developed the endoscopic microscope, said, “My dream is to disseminate this technology to a broad scope of medical facilities, hospitals and various clinics, of course, but also to take it into underserved and rural, even remote, areas. Its compactness and portability will allow us to do this.”

Related Links:

University of Arkansas
M.D. Anderson Cancer Center 



DiagCor Bioscience
DRG International
77 ELEKTRONIKA
comments powered by Disqus
Life Technologies

Channels

Clinical Chemistry

view channel
Image: The gel zymography separation of matrix metalloproteinases (MMPs) on a 7.5% polyacrylamide gel (Photo courtesy of the Italian National Research Council).

Quantitative Gel Zymography Reappraised for Matrix Metalloproteinases

A reappraisal of quantitative gel zymography technique for matrix metalloproteinases (MMPs) in human plasma has been used for comparison with commercially available enzyme-linked immunosorbent assay (ELISA).... Read more

Industry News

view channel

French-German Cooperation to Improve Personalized Cancer Care

A leading French oncology center will be collaborating with a German manufacturer of molecular diagnostic tests to develop new approaches to personalized cancer care. The Gustave Roussy Cancer Campus (Paris, France), a medical center with 2,600 health professionals dedicated to cancer diagnosis and treatment that devotes... Read more
 

Events

06 Nov 2014 - 08 Nov 2014
12 Nov 2014 - 15 Nov 2014
Copyright © 2000-2014 Globetech Media. All rights reserved.